Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 05/06/25
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in NevadaGlobeNewsWire • 04/16/25
Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/31/25
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational UpdateGlobeNewsWire • 03/31/25
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference CallGlobeNewsWire • 03/28/25
Vivos Therapeutics sees strong adoption of OSA treatment, expands strategic allianceProactive Investors • 02/24/25
Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 12/23/24
All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to BuyZacks Investment Research • 12/18/24
Vivos Therapeutics eyes positive cash flow as it continues cost-reduction success in Q3Proactive Investors • 11/14/24
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference CallGlobeNewsWire • 11/13/24
Vivos Therapeutics wins approval for streamlined insurance reimbursement for sleep apnea treatmentProactive Investors • 10/08/24
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical AssociationGlobeNewsWire • 10/08/24
Vivos Therapeutics' oral device approved by FDA for pediatric sleep apnea treatmentProactive Investors • 09/18/24
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and SnoringGlobeNewsWire • 09/18/24
Vivos Therapeutics boosts Q2 revenue, cuts operating losses amid new strategic partnershipsProactive Investors • 08/14/24
Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational UpdateGlobeNewsWire • 08/14/24
Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference CallGlobeNewsWire • 08/14/24
Vivos Therapeutics reports positive results from pilot of provider-based modelProactive Investors • 06/27/24
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution ModelGlobeNewsWire • 06/27/24